Clinical Trial: Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Retrospective Evaluation of Treatments and Outcomes Associated With Antivenom Therapy For Crotaline Snakebite - A Comparison Of Severe To Mild/Moderate Envenomations
Brief Summary: Retrospective observational review of severe envenomation treatment with CroFab
Detailed Summary: The objective of this study is to use previously collected retrospective observational data to compare treatment and outcome in patients treated with CroFab who have a severe envenomation to those with a mild/moderate envenomation.
Sponsor: BTG International Inc.
Current Primary Outcome: Severity score: in order to assess response to therapy, severity scores were calculated and compared across all recorded time points. [ Time Frame: at baseline and following treatment with CroFab ]
Original Primary Outcome: Same as current
Current Secondary Outcome: The presence of venom effects, comparison of venom effects over time, initial control of venom effects, recurrence of venom effects, and delayed onset of venom effects. [ Time Frame: following treatment ]
Original Secondary Outcome: Same as current
Information By: BTG International Inc.
Dates:
Date Received: June 23, 2009
Date Started: January 2005
Date Completion:
Last Updated: June 24, 2009
Last Verified: June 2009